Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,380−100.0%Sold outHolders
Q1 20261,380$55.5K<0.1%−1,662−54.6%ReducedHolders
Q4 20253,042$76.4K<0.1%+376+14.1%AddedHolders
Q3 20252,666$60.3K<0.1%−390−12.8%ReducedHolders
Q2 20253,056$52.9K<0.1%+711+30.3%AddedHolders
Q1 20252,345$51.3K<0.1%−878−27.2%ReducedHolders
Q4 20243,223$102.8K<0.1%+1,327+70.0%AddedHolders
Q3 20241,896$54.7K<0.1%−983−34.1%ReducedHolders
Q2 20242,879$110.4K<0.1%−687−19.3%ReducedHolders
Q1 20243,566$209.6K<0.1%−274−7.1%ReducedHolders
Q4 20233,840$229.9K<0.1%−58−1.5%ReducedHolders
Q3 20233,898$148.3K<0.1%+2,564+192.2%AddedHolders
Q2 20231,334$121.5K<0.1%+23+1.8%AddedHolders
Q1 20231,311$86.5K<0.1%+597+83.6%AddedHolders
Q4 2022714$36.9K<0.1%−3,553−83.3%ReducedHolders
Q3 20224,267$291.0K<0.1%+3,902+1,069.0%AddedHolders
Q2 2022365$17.0K<0.1%−745−67.1%ReducedHolders
Q1 20221,110$56.0K<0.1%+884+391.2%AddedHolders
Q4 2021226$11.0K<0.1%−117−34.1%ReducedHolders
Q3 2021343$12.0K<0.1%+203+145.0%AddedHolders
Q2 2021140$9.00K<0.1%+33+30.8%AddedHolders
Q1 2021107$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.